Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

This grant opportunity, PAR-25-051, is for the Blueprint Neurotherapeutics Network (BPN) and supports small molecule drug discovery and development for disorders of the nervous system. It utilizes a UG3/UH3 phased award mechanism and includes an optional clinical trial component.